1. Home
  2. VYGR vs GNTY Comparison

VYGR vs GNTY Comparison

Compare VYGR & GNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • GNTY
  • Stock Information
  • Founded
  • VYGR 2013
  • GNTY 1913
  • Country
  • VYGR United States
  • GNTY United States
  • Employees
  • VYGR N/A
  • GNTY N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • GNTY Major Banks
  • Sector
  • VYGR Health Care
  • GNTY Finance
  • Exchange
  • VYGR Nasdaq
  • GNTY Nasdaq
  • Market Cap
  • VYGR 386.1M
  • GNTY 407.7M
  • IPO Year
  • VYGR 2015
  • GNTY 2017
  • Fundamental
  • Price
  • VYGR $5.43
  • GNTY $37.12
  • Analyst Decision
  • VYGR Strong Buy
  • GNTY Hold
  • Analyst Count
  • VYGR 8
  • GNTY 3
  • Target Price
  • VYGR $17.00
  • GNTY $35.00
  • AVG Volume (30 Days)
  • VYGR 583.2K
  • GNTY 17.8K
  • Earning Date
  • VYGR 11-12-2024
  • GNTY 01-14-2025
  • Dividend Yield
  • VYGR N/A
  • GNTY 2.66%
  • EPS Growth
  • VYGR N/A
  • GNTY N/A
  • EPS
  • VYGR 0.47
  • GNTY 2.38
  • Revenue
  • VYGR $163,784,000.00
  • GNTY $117,228,000.00
  • Revenue This Year
  • VYGR N/A
  • GNTY N/A
  • Revenue Next Year
  • VYGR N/A
  • GNTY $4.44
  • P/E Ratio
  • VYGR $11.65
  • GNTY $15.17
  • Revenue Growth
  • VYGR 3.40
  • GNTY N/A
  • 52 Week Low
  • VYGR $5.19
  • GNTY $27.01
  • 52 Week High
  • VYGR $11.72
  • GNTY $37.28
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 34.18
  • GNTY 61.30
  • Support Level
  • VYGR $5.19
  • GNTY $35.79
  • Resistance Level
  • VYGR $5.59
  • GNTY $36.79
  • Average True Range (ATR)
  • VYGR 0.41
  • GNTY 1.12
  • MACD
  • VYGR -0.19
  • GNTY 0.18
  • Stochastic Oscillator
  • VYGR 10.71
  • GNTY 100.00

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About GNTY Guaranty Bancshares Inc.

Guaranty Bancshares Inc is a bank holding company conducting banking activities through its wholly-owned subsidiary. The company provides its customers with a full array of relationship-driven commercial and consumer banking products and services, as well as mortgage, trust, and wealth management products and services that are tailored to meet the needs of small and medium-sized businesses, professionals, and individuals. It also provides other services such as Credit cards, Personal Loans, Business Checking, Treasury Management, and other related services. The company generates its revenue from interest on loans and investments, customer service and loan fees, fees related to the sale of mortgage loans, and trust and wealth management services.

Share on Social Networks: